Professional Documents
Culture Documents
This module is designed for management and prevention of complications in neonates likely to
be affected by COVID-19 as a result of outbreak of third wave. In an attempt to prevent
complications it is mandatory to ensure availability of man material resources and its
implementation.
AIM :
To improve the effective timely diagnosis, treatment, rehabilitation, preventive medical care and
quality management system.
The purpose of this protocol is to ensure the safety of patients who need neonatal critical
care during the COVID-19 pandemic, while protecting staff from infection. The processes
outlined here
OBJECTIVES
1. Protection of staff from exposure and infection
2. Conservation of PPE and resources
3. Mitigation of stress on staff and patients/families
4. General information/algorithms for care and treatment
GOALS
A. ensure proper airway
B. ensure adequate oxygenation n ventilation
C. maintain hemodynamic stability
D. prevention of infection
E. prevent further complications
INTRODUCTION
The Transmission of SARS-CoV-2, to neonates is thought to be predominately to occur primarily
through respiratory droplets during the postnatal period when neonates are exposed to mothers or
other caregivers with SARS-CoV-2 infection. Limited published reports have raised concern
about possible intrauterine, intrapartum, or peripartum transmission Approximately 2-5% of
infants born to mother with positive COVID-19 have positive SARS-CoV-2 positive test in the
first 24-96 hrs. Their immature immune system leaves newborns vulnerable to other Severe
respiratory viral infections, which may cause severe disease among neonates.
This document provides interim guidance for the management of infants born to mothers with
confirmed or suspected COVID-19 infection.
Neonates born to the mothers who are suspected or confirmed COVID-19 infection can be
divided to three main groups:
1. Healthy baby
2. Asymptomatic infected (or mild disease) neonate born at or near term who does not require
neonatal intensive care.
3. Symptomatic or high-risk neonates requiring neonatal intensive care admission. (Preterm
infants)
ADMISSION PROCESS
1.Follow the admission criteria of NICU
2.All Patients under Investigation (PUI) or confirmed COVID patients that require NICU
admission will be evaluated and then admit.
● Direct Admissions from an outside hospital
A. Please remind all healthcare workers every time what are the requirements for PPE
B. At the time that a patient is accepted to the NICU.
C. See attached admissions algorithm n check-list
D. We will continue to adhere to all the same standards and protocols
E. when accepting a patient from an outside hospital /OR similar hospital (pediatric ward)
check the condition
F. A NICU Attending will accept a patient based on NICU admission criteria
G. The information will be communicated to the charge nurse to determine bed and staff
availability
H. Take high risk consent
I. Caretakers must be told about our visitor policy ( 1 visitor only) explain them the
language they understand to avoid unnecessary conflict and anxiety to families when
additional visitors are not allowed in.
J. Care taker should be with proper mask, gloves, and appropriate PPE.
K. Teach them about proper hand washing, use of sanitizer and proper distancing.
Clinical Manifestations:
Clinical Findings:
Neonates with COVID-19 infection are classified according to the presence or absence of
apparent symptoms and signs. The clinical manifestations may be asymptomatic, mild, or
severe. Clinical findings, especially in premature infants, are nonspecific Therefore, it is
important to closely monitor vital signs, respiratory and gastrointestinal symptoms and signs.
The signs may include:
a. Temperature instability: the temperature of an infected infant may be elevated,
depressed, or normal.
b. Respiratory and cardiovascular signs may include tachypnea, grunting, nasal flaring,
increased work of breathing (WOB), apnea, cough, or tachycardia.
c. other findings may include poor feeding, lethargy, vomiting, loose stools, and
abdominal distension
Laboratory finding:
Laboratory examinations may be non-specific.
Complete blood count (CBC) may show normal or decreased leukocyte counts, or decreased
lymphocyte counts.
Other findings may include: a. mild thrombocytopenia b. elevated levels of creatine kinase,
alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, and lactate
dehydrogenase
COVID-19 can be detected by PCR:
a. Upper respiratory tract (URT; nasopharyngeal and oropharyngeal),
b. Lower respiratory tract (LRT; an endotracheal aspirate, or bronchoalveolar lavage)
c. The blood by serology test
d. The Stool by PCR
Radiography findings: a. Chest radiograph or lung ultrasound is likely to show pneumonia b.
Abdominal radiograph may show the characteristic radiographic features of intestinal ileus.
If the mother’s result is tested positive for COVID – 19 infections and the neonate
1st swab result is Positive:
1. Continue close monitoring and supportive care management.
2. Repeat the sample every 48 - 72 hours’ intervals until the result turns negative
3. If the neonate is fit for discharge, Discharge with COVID – 19 negative caregivers
Once negative for two Consecutive samples.
4. Transfer the baby from the isolation room or discontinue the isolation after the
2 negative consecutive swab results.
RESPIRATORY MANAGEMENT OF SICK NEWBORN
ON DISCHARGE
To strictly give exclusive breastfeeding up to 6 months of age.
Avoid unnecessary handling of the baby and limit exposure with relatives.
Maintain proper hand hygiene or alcohol-based rub.
Strictly adhere to the immunization of child as per national immunization schedule.
Follow-up in opd as per doctors advice.
-
REFERANCES
1.Sankaran D, Nakra N, Cheema R, Blumberg D, Lakshminrusimha S. Perinatal SARS-CoV-2
Infection and Neonatal COVID-19: A 2021 Update. Neoreviews. 2021 May;22(5):e284-e295.
doi: 10.1542/neo.22-5-e1001. PMID: 33931474.
2. COVID19 India. Accessed 28 January 2021. Available at https://www.mohfw.gov.in/ 2. Guan
WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J
Med. 2020;382:1708-720. 3. Fox NS, Melka S. COVID-19 in pregnant women: Case series from
one large New York city obstetrical practice. Am J Perinatol. 2020;37:1002-04.
4. Raschetti R, Vivanti AJ, Vauloup-Fellous C, et al. Synthesis and systematic review of reported
neonatal SARS-CoV-2 infections. Nature Communications. 2020;11:5164.
5. Sheth S, Shah N, Bhandari V. Outcomes in COVID-19 Positive Neonates and Possibility of
Viral Vertical Transmission: A Narrative Review. Am J Perinatol. 2020;37:1208-16.